Stock info Abbott | Filter  Basic-Info

Stock: Abbott (US broad), ISIN: US0028241000

Last Price 111.51 Max Price 120.96
Min Price 90.19 1 Year return -20.77
Sector Health Care Subsector Health Care Eq. & Services
Annual report 2017

Abbott (previously known as Abbott alkaloid Company) is well known pharmaceutical company listed in S&P 500. The company is having approximately 90,000 employees in over 130 countries. Abbott was founded in 1888 by Wallace C. Abbott and is having its headquarters in Abbott Park, a northern suburb of Chicago, Illinois.

Loading...

Contact info:Street: 100 Abbott Park RoadZip Code: IL 600646400City: Abbott ParkCountry: USAPhone: (847) 9376100Website: www.abbott.comCEO: Miles D. WhiteCFO: Thomas C. Freyman

Sector Review Abbott

Loading...
Year Turnover Total sector Market share
2019 31,904 2,019,627 1.58 %
2020 34,608 2,170,562 1.59 %
2021 43,075 2,404,921 1.79 %
2022 43,653 2,645,840 1.65 %
2023 0 0 0.00 %

Advice Abbott

Date Label Bank Label Stock Label Advice Label Price Label Diff Label
September 22, 2014 RBC Capital Markets Abbott Buy 48.00 -143.50 %



News Abbott

Analysts expect over 2023 revenue increase Abbott

Tomorrow Abbott will publish its past quarters results. Over the current book year the total revenu from the company based in will be 39.9 billion USD (consensus estimates). This is slightly lower than 2022's revenue of 43.65 billion USD. Historical revenues...

Analysts: more sales Abbott

Tomorrow the American Abbott will publish its past quarters figures. For this year Abbott 's revenue will be around 39.96 billion USD. This is according to the average of the analysts' estimates. This is rather significant more than 2021's revenue of 34.61 billion...

Analysts expect revenue increase Abbott

Tomorrow Abbott will publish it's past quarters results. For this year the company, based in Abbott Park revenue will be around 39.29 billion USD. This is according to the average of the analysts' estimates. This is quite more than 2021's revenue of 34.61 billion...

Analysts expect revenue increase Abbott

Tomorrow Abbott will publish its past quarters results. Over the current book year the total revenue from the company in Abbott Park will be 39.29 billion USD (consensus estimates). This is quite more than 2020's revenue of 34.61 billion USD. Historical revenues...

Analysts expect over 2021 rising revenue Abbott

Tomorrow the American company Abbott will publish its past quarter results. Over the current book year the company from Abbott Park's total revenue could be around 42.2 billion USD (consensus estimates). This is hugely more than 2020's revenue of 34.61 billion...

Annual reports Abbott

2017 2018 2019 2020 2021

Profile Abbott

Abbott

(US0028241000)/ ABT

The headquarter of Abbott is based in Abbott Park. The core activities of Abbott are in the pharmaceutical sector. Miles D. White manages the company as a CEO. Thomas C. Freyman runs the company as a CFO. The past 10 years the (international) industry gained at around 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-2016) there is a minus of 75 percent.

The past year was a profitable year Abbott investors

The period between December 2015 and December 2016 was a bad period for the investors. The stock lost almost 13 percent. Abbott' stock rose the past 5 years at around 44 percent. Abbott's revenues between 2011 and 2015 were far from constant and moved between 39,87 billion dollars and 20,41 billion dollars. The net results between 2011 and 2015 were far from constant and fluctuated between 4,73 billion dollars and 2,61 billion dollars.

The American company paid out dividends in the past 5 years. Over the past 5 years Abbott's dividend yield was at around 6,11 percent per year. Over the past 5 years the company raised it's dividends each year. Because of the yearly increased dividends Abbott can be called a kind of dividend aristocrat.

Abbott financed with relatively low debt

At the end of 2015 the American company had a balance sheet of 41,25 billion dollars. 20,04 billion dollars (48,58 percent of the total balance sheet) was financed by debt. Last year the pharmaceutical company's price/earnings-ratio (PE) was around 25. So the investors valued the stock at 25 times 2015' earnings per share. Based on the classical stock valuation theories the American stock can be seen as a value stock.

At the end of 2015 the market capitalization (the number of shares outstanding multiplied by the stock price) of the pharmaceutical company equaled around 63,56 billion dollars. At the end of 2015 around 1,47 billion stocks were listed.

All Abbott's financial reports are available here. More information about Abbott can be found it's website. .


Results Abbott

Results
2015
2016
2017
2018
2019
2020
Revenue
20,405
20,853
27,390
30,578
31,904
34,608
Costs
15,982
19,453
26,913
28,210
28,217
30,113
Profit
4,423
1,400
477
2,368
3,687
4,495
Margin of profit
21.68
6.71
1.74
7.74
11.56
12.99
ROI
20.85
6.82
1.54
7.76
11.86
13.71

Balance Abbott

Balance
2015
2016
2017
2018
2019
2020
Equity
21,211
20,538
30,897
30,524
31,088
32,784
Debt
20,036
32,128
45,353
36,649
36,799
39,764
Total assets
41,247
52,666
76,250
67,173
67,887
72,548
Solvency
51.42
39.00
40.52
45.44
45.79
45.19
Cash
6,125
18,775
9,610
4,086
4,140
7,148
Cashflow
2,966
3,203
5,570
6,300
6,136
7,901
Employees
0
0
0
0
0
Revenue per employee
0.0
0.0
0.0
0.0
0.0
Cashflow / Debt
0.15
0.10
0.12
0.17
0.17
0.20

Details Abbott

Details
2016
2017
2018
2019
2020
Price
44.91
38.41
57.07
72.33
86.86
Eps
0.94
0.27
1.34
2.07
2.52
Price/earnings-ratio
47.78
142.26
42.59
34.94
44.25
Dividend
1.04
1.06
1.12
1.28
1.44
Dividend %
2.32 %
2.76 %
1.96 %
1.77 %
1.29 %
Payout %
1.11
3.93
0.84
0.62
0.57
Book value
13.94
17.72
17.39
17.64
18.51
Market to book
0.31
0.46
0.30
0.24
0.17
Cashflow per stock
2.17
3.19
3.59
3.48
4.46
Stocks
1,473
1,744
1,756
1,763
1,771
Market Cap
66.146.56
66.971.77
100.193.23
127.481.63
197.509.86

Dividend Abbott


Price info Abbott

Date
Price
22 Mar 2024
111.51
18 Mar 2024
112.44
15 Mar 2024
118.85
12 Mar 2024
120.19
11 Mar 2024
120.96
09 Mar 2024
120.96
07 Mar 2024
119.34
01 Mar 2024
118.64
29 Feb 2024
120.05
27 Feb 2024
118.69
22 Feb 2024
117.87
21 Feb 2024
116.64
20 Feb 2024
114.01
15 Feb 2024
112.06
14 Feb 2024
111.34
13 Feb 2024
112.53
09 Feb 2024
112.43
08 Feb 2024
113.31
07 Feb 2024
114.00
06 Feb 2024
111.65
05 Feb 2024
112.11
01 Feb 2024
113.15
31 Jan 2024
113.48
30 Jan 2024
113.45
27 Jan 2024
112.01
25 Jan 2024
110.77
24 Jan 2024
114.00
23 Jan 2024
114.19
16 Jan 2024
113.92
11 Jan 2024
114.40